Abstract:Background and aims: Biological mechanisms that control liver regeneration remain poorly defined. However, these mechanisms are remarkable issues in the clinic that affect management of hepatic loss caused by liver surgery, traumatic injury, chronic infection, or liver poisoning. Increasing evidence has shown that various growth factors, cytokines, and metabolic signaling pathways affect the liver regenerative process. Our aim is to study the effect of bromodomain and extraterminal (BET) protein inhibition on liver regeneration and its mechanism. Methods: We studied the role of BET protein inhibitor, JQ1, in liver regeneration in a mouse model after 70% partial hepatectomy (PH). We evaluated yes-associated protein (YAP)/transcriptional co-activator with PDZ-binding motif (TAZ) and Notch signaling pathways, which were affected by BET protein inhibitor in mouse hepatic tissues and primary hepatocytes in vivo and AML12 cell lines in vitro. We evaluated the relationship of YAP/TAZ and Notch signaling pathway using YAP/TAZ pathway inhibitor in liver regeneration in vivo. Moreover, we analyzed the relationship of YAP/TAZ and Notch signaling pathways via overexpression or RNA silencing of Yap in AML12 cells. Furthermore, we used Yap overexpression mouse model to examine whether it can rescue liver regeneration damage caused by inhibition of BET proteins. Results: In this study, we report that BET protein inhibitor JQ1 molecule impairs the early phase of liver regeneration in a mouse model after 70% PH. Mechanistically, YAP/TAZ and Notch1-NICD pathways were suppressed by BET protein inhibitor in mouse hepatic tissues and primary hepatocytes in vivo and mouse AML12 cell lines in vitro. By using YAP/TAZ pathway inhibitor, we confirmed that the liver regeneration and the activation of Notch pathway were impaired by the inhibition of YAP/TAZ pathway in vivo. Furthermore, the study showed that Yap knockdown by shRNA in normal mouse hepatic cell line downregulated Notch1 signal transduction, whereas Yap overexpression promoted Notch1-NICD signals. Specific overexpression of Yap in mouse liver could rescue the effect of BET protein inhibition on liver regeneration injury. Conclusion: These results revealed the crucial role of the YAP/TAZ-Notch1-NICD axis in liver regeneration. Therefore, BET protein inhibitors must be used in caution in the treatment of hepatic diseases by reason of its suppressive roles in liver regeneration.

Loss of Gsα impairs liver regeneration through a defect in the crosstalk between cAMP and growth factor signaling

Regulation of mice liver regeneration by early growth response-1 through the GGPPS/RAS/MAPK pathway.

Suppression of Liver Regeneration and Hepatocyte Proliferation in Hepatocyte-Targeted Glypican 3 Transgenic Mice

CREBZF as a Key Regulator of STAT3 Pathway in the Control of Liver Regeneration in Mice

Endothelial G protein stimulatory α-subunit is a critical regulator of post-ischemic angiogenesis

Suppression of YAP/TAZ-Notch1-NICD axis by bromodomain and extraterminal protein inhibition impairs liver regeneration.

Loss of α-catenin elicits a cholestatic response and impairs liver regeneration

Loss Of Alpha-Catenin Elicits A Cholestatic Response And Impairs Liver Regeneration

Endothelial G protein stimulatory alpha-subunit is a critical regulator of post-ischemic angiogenesis

Loss of transforming growth factor β adaptor protein β-2 spectrin leads to delayed liver regeneration in mice.

Hepatic regulator of G protein signaling 14 ameliorates NAFLD through activating cAMP-AMPK signaling by targeting Giα1/3

Gsα deficiency facilitates cardiac remodeling via CREB/ Bmp10-mediated signaling

Hepatic Regulator of G Protein Signaling 5 Ameliorates Nonalcoholic Fatty Liver Disease by Suppressing Transforming Growth Factor Beta–Activated Kinase 1–c‐Jun‐N‐Terminal Kinase/p38 Signaling

Deletion of Golgi Protein 73 Delayed Hepatocyte Proliferation of Mouse in the Early Stages of Liver Regeneration.

Hepatocyte-Specific Deletion of Cdc42 Results in Delayed Liver Regeneration after Partial Hepatectomy in Mice

Liver Regeneration Deficit in Mice Following Egfr and Met Elimination

Regulator of G‐protein signaling 14 protects the liver from ischemia–reperfusion injury by suppressing TGF‐β‐activated kinase 1 activation

Rna Interference Against Hepatic Epidermal Growth Factor Receptor Has Suppressive Effects on Liver Regeneration in Rats

Enhanced Liver Regeneration Following Changes Induced by Hepatocyte-Specific Genetic Ablation of Integrin-Linked Kinase

Deletion of GPR81 Activates CREB/Smad7 Pathway and Alleviates Liver Fibrosis in Mice

Loss of Regulator of G Protein Signaling 5 Exacerbates Obesity, Hepatic Steatosis, Inflammation and Insulin Resistance